Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
6,93 AUD | -2,39% | +4,05% | +12,68% |
Attività
Numero di dipendenti: 967
Vendite per attività
AUD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
International
35,2
%
| 54 | 12,8 % | 65 | 35,2 % | +19,01% |
Branded Products Division
33,7
%
| 11 | 2,5 % | 62 | 33,7 % | +485,69% |
Portfolio Products Division
31,0
%
| 269 | 63,3 % | 57 | 31,0 % | -78,82% |
Vendite per regione
AUD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
67,8
%
| 371 | 87,3 % | 124 | 67,8 % | -66,44% |
Australia and New Zealand
22,4
%
| 34 | 7,9 % | 41 | 22,4 % | +22,24% |
Canada
5,4
%
| 9 | 2,1 % | 10 | 5,4 % | +9,62% |
Asia
2,4
%
| 5 | 1,1 % | 4 | 2,4 % | -9,86% |
Europe and Other
2,0
%
| 6 | 1,5 % | 4 | 2,0 % | -42,36% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Shawn O'Brien
CEO | Chief Executive Officer | - | 01/10/22 |
Aaron Gray
DFI | Director of Finance/CFO | - | 29/08/22 |
Keith Moore
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/15 |
Gerard G. Nahum
CTO | Chief Tech/Sci/R&D Officer | - | - |
Frank Casty
CTO | Chief Tech/Sci/R&D Officer | - | - |
Craig Haskins
IRC | Investor Relations Contact | - | - |
Erinn Nathaniel
HRO | Human Resources Officer | - | - |
Kimberly Parker
LAW | General Counsel | - | - |
Richard Moldin
PRN | Corporate Officer/Principal | - | - |
Laura Loftus
PRN | Corporate Officer/Principal | - | 26/03/20 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Frank Condella
CHM | Chairman | 70 | 30/05/18 |
Patrick Blake
BRD | Director/Board Member | 59 | 28/06/18 |
Shawn O'Brien
CEO | Chief Executive Officer | - | 01/10/22 |
Director/Board Member | 58 | 01/02/22 | |
Bruce Robinson
BRD | Director/Board Member | 67 | 26/08/14 |
Anne Lockwood
BRD | Director/Board Member | - | 30/11 |
Ann Custin
BRD | Director/Board Member | 64 | 23/03/22 |
David Petrie
BRD | Director/Board Member | - | 01/09/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 81 245 827 | 57 414 136 ( 70,67 %) | 0 | 70,67 % |
Coordinate società
Mayne Pharma Group Ltd.
1538 Main North Road Salisbury South
5106, Salisbury
+61 8 8209 2666
http://www.maynepharma.comSettore
Vendite per attività
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+12,68% | 367 Mln | |
+19,62% | 43,34 Mrd | |
+20,44% | 21,96 Mrd | |
+10,86% | 14,09 Mrd | |
+13,07% | 13,64 Mrd | |
+37,46% | 11,43 Mrd | |
-8,59% | 6,86 Mrd | |
-0,05% | 6,79 Mrd | |
-8,87% | 5,73 Mrd | |
+8,46% | 5,22 Mrd |
- Borsa valori
- Azioni
- Azione MYX
- Società Mayne Pharma Group Limited